Review: Biological and Pharmacological Basis of Cytolytic Viral Activation in EBV-Associated Nasopharyngeal Carcinoma

doi 10.5772/64738
Full Text
Abstract

Available in full text

Date
Authors
Publisher

InTech

Related search

MicroRNA-183 Suppresses Cancer Stem-Like Cell Properties in EBV-associated Nasopharyngeal Carcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Overexpression of PIN1 Enhances Cancer Growth and Aggressiveness With Cyclin D1 Induction in EBV-Associated Nasopharyngeal Carcinoma

PLoS ONE
Multidisciplinary
2016English

The Prognostic Significance of Carcinoma-Associated Fibroblasts and Tumor-Associated Macrophages in Nasopharyngeal Carcinoma

Cancer Management and Research
Oncology
2018English

EBV-miR-BART7-3p Imposes Stemness in Nasopharyngeal Carcinoma Cells by Suppressing SMAD7

Frontiers in Genetics
GeneticsMolecular Medicine
2019English

Novel Patterns of the Epstein-Barr Nuclear Antigen (EBNA-1) V-Val Subtype in EBV-associated Nasopharyngeal Carcinoma From Vietnam

Balkan Journal of Medical Genetics
Genetics
2019English

Functional Inactivation of EBV-Specific T-Lymphocytes in Nasopharyngeal Carcinoma: Implications for Tumor Immunotherapy

PLoS ONE
Multidisciplinary
2007English

Treatment of Locally Recurrent Epstein–barr Virus-Associated Nasopharyngeal Carcinoma Using the Anti-Viral Agent Cidofovir

Journal of Medical Virology
VirologyInfectious Diseases
2008English

EBV Encoded miRNA BART8-3p Promotes Radioresistance in Nasopharyngeal Carcinoma by Regulating ATM/ATR Signaling Pathway

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2019English

Optimal Sequencing of Chemotherapy With Chemoradiotherapy Based on TNM Stage Classification and EBV DNA in Locoregionally Advanced Nasopharyngeal Carcinoma

Cancer Communications
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy